Worth Venture Partners, LLC - Q4 2020 holdings

$126 Million is the total value of Worth Venture Partners, LLC's 101 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 173.7% .

 Value Shares↓ Weighting
NewUNITED STATES STL CORP NEWnote 5.000%11/0$6,955,0004,625,000
+100.0%
5.51%
NewWORKDAY INCnote 0.250%10/0$6,051,0003,614,000
+100.0%
4.79%
COHU NewCOHU INC$5,611,000146,971
+100.0%
4.44%
OIIM BuyO2MICRO INTERNATIONAL LIMITEspons adr$4,270,000
+296.5%
465,169
+52.8%
3.38%
+283.0%
BLBD NewBLUE BIRD CORP$3,791,000207,618
+100.0%
3.00%
NewNUANCE COMMUNICATIONS INCnote 1.250% 4/0$3,673,0001,610,000
+100.0%
2.91%
CLDR NewCLOUDERA INC$3,525,000253,400
+100.0%
2.79%
FFIV NewF5 NETWORKS INC$3,344,00019,005
+100.0%
2.65%
BuySPIRIT AIRLS INCnote 4.750% 5/1$3,217,000
+188.0%
1,497,000
+94.9%
2.55%
+178.2%
EMKR BuyEMCORE CORP$3,193,000
+452.4%
585,833
+229.9%
2.53%
+433.5%
COHR NewCOHERENT INC$2,996,00019,969
+100.0%
2.37%
AVNW NewAVIAT NETWORKS INC$2,028,00059,382
+100.0%
1.61%
SILC BuySILICOM LTDord$1,940,000
+45.4%
46,364
+12.6%
1.54%
+40.4%
LPTH NewLIGHTPATH TECHNOLOGIES INC$1,842,000469,878
+100.0%
1.46%
NewRAPID7 INCnote 1.250% 8/0$1,798,000826,000
+100.0%
1.42%
ATEN BuyA10 NETWORKS INC$1,690,000
+55.0%
171,376
+0.1%
1.34%
+49.7%
PXLW BuyPIXELWORKS INC$1,199,000
+137.9%
425,351
+73.1%
0.95%
+130.0%
PRTK BuyPARATEK PHARMACEUTICALS INC$1,196,000
+28.2%
191,093
+10.8%
0.95%
+23.8%
VNDA BuyVANDA PHARMACEUTICALS INC$1,171,000
+46.6%
89,124
+7.7%
0.93%
+41.5%
CPRX BuyCATALYST PHARMACEUTICALS INC$1,151,000
+44.2%
344,702
+28.3%
0.91%
+39.2%
LUNA BuyLUNA INNOVATIONS$1,114,000
+111.0%
112,712
+27.6%
0.88%
+103.7%
SBBP BuySTRONGBRIDGE BIOPHARMA PLC$1,091,000
+129.2%
449,046
+98.1%
0.86%
+121.5%
NewPALO ALTO NETWORKS INCnote 0.750% 7/0$877,000620,000
+100.0%
0.70%
MYO NewMYOMO INC$739,000109,864
+100.0%
0.58%
ETSY NewETSY INC$720,0004,048
+100.0%
0.57%
NMTR New9 METERS BIOPHARMA INC$678,000789,341
+100.0%
0.54%
ZUO NewZUORA INC$664,00047,682
+100.0%
0.53%
ALNA BuyALLENA PHARMACEUTICALS INC$653,000
+7.9%
510,200
+24.8%
0.52%
+4.2%
RIGL NewRIGEL PHARMACEUTICALS INC$622,000177,810
+100.0%
0.49%
ARDS NewARIDIS PHARMACEUTICALS INC$534,00087,932
+100.0%
0.42%
EDAP NewEDAP TMS S Asponsored adr$523,000101,082
+100.0%
0.41%
HEPA NewHEPION PHARMACEUTICALS INC$512,000233,947
+100.0%
0.40%
AGX BuyARGAN INC$508,000
-3.4%
7,513
+0.9%
0.40%
-6.7%
PXD NewPIONEER NAT RES CO$397,0003,489
+100.0%
0.31%
CTO BuyCTO REALTY GROWTH INC$391,000
+20.7%
9,280
+26.3%
0.31%
+16.5%
CYTH NewCYCLO THERAPEUTICS INC$386,00088,690
+100.0%
0.31%
THTX NewTHERATECHNOLGIES INC$365,000146,162
+100.0%
0.29%
SLRX BuySALARIUS PHARMACEUTICALS INC$328,000
+50.5%
360,556
+39.6%
0.26%
+45.3%
NDRA NewENDRA LIFE SCIENCES INC$247,000329,420
+100.0%
0.20%
NLY BuyANNALY CAPITAL MANAGEMENT IN$230,000
+50.3%
27,200
+26.5%
0.18%
+44.4%
DAIO NewDATA I O CORP$208,00050,387
+100.0%
0.16%
NewFORD MTR CO DELcall$139,000380,100
+100.0%
0.11%
CDR NewCEDAR REALTY TRUST INC$112,00011,055
+100.0%
0.09%
CYTHW NewCYCLO THERAPEUTICS INC*w exp 11/14/202$96,00088,690
+100.0%
0.08%
PBLA NewPANBELA THERAPEUTICS INC$78,00021,794
+100.0%
0.06%
NewISHARES TRput$64,000103,800
+100.0%
0.05%
NewGENERAL MTRS COcall$60,000114,000
+100.0%
0.05%
BuySPIRIT AIRLS INCput$24,000
-35.1%
55,900
+46.0%
0.02%
-36.7%
BuyCINEMARK HLDGS INCput$18,000
-81.1%
130,700
+13.5%
0.01%
-82.1%
NewVERITONE INCput$7,00014,600
+100.0%
0.01%
NewLIVENT CORPput$2,00010,300
+100.0%
0.00%
BuyNIO INCput$0
-100.0%
71,200
+0.8%
0.00%
-100.0%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-17
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
AIRGAIN ORD25Q3 20231.8%
PIXELWORKS ORD23Q3 20221.3%
SILICOM ORD22Q3 20231.8%
DSP GROUPS INC20Q3 20211.4%
DIGITAL TURBINE ORD19Q2 20231.0%
BK OF AMERICA CORP17Q3 20231.1%
EQUITY COMWLTH REIT ORD17Q3 20230.7%
ISHARES TR16Q4 20203.0%
SCPHARMACEUTICALS ORD16Q3 20232.8%
SELECT SECTOR SPDR TR16Q4 20201.3%

View Worth Venture Partners, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-09
13F-HR2023-11-15
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Worth Venture Partners, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (126406000.0 != 126274000.0)

Export Worth Venture Partners, LLC's holdings